CD8A and melanoma: Consistent with these findings, ectopic expression of NIK, a kinase specifically targeted by TNFRs such as 4-1BB and OX40, prevents CD8+ T-cell exhaustion and promotes CD8+ T-cell metabolism and antitumor immunity in MC38 colon cancer and B16 melanoma mouse tumor models [110].